We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+3.9%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$45.7B
AUM Growth
+$116M
(+0.25%)
Cap. Flow
-$39.4M
Cap. Flow
% of AUM
-0.09%
Top 10 Holdings %
Top 10 Hldgs %
13.84%
Holding
2,228
New
172
Increased
849
Reduced
944
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$176M |
| 2 |
Johnson & Johnson
JNJ
|
+$157M |
| 3 |
AbbVie
ABBV
|
+$128M |
| 4 |
Amgen
AMGN
|
+$115M |
| 5 |
GE Vernova
GEV
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Entergy
ETR
|
+$152M |
| 2 |
Dominion Energy
D
|
+$132M |
| 3 |
Applovin
APP
|
+$114M |
| 4 |
Morgan Stanley
MS
|
+$108M |
| 5 |
BCE
BCE
|
+$99.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Healthcare | 15.8% |
| 3 | Financials | 14.36% |
| 4 | Industrials | 10.83% |
| 5 | Consumer Discretionary | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Adaptive Biotechnologies
ADPT
$4.26B
| $47.8K | ﹤0.01% |
7,970
-3,289
| -29% | -$18.1K |
|
1677
Patrick Industries
PATK
$2.27B
| $47.7K | ﹤0.01% |
574
-142
| -20% | -$12.7K |
|
1678
Shutterstock
SSTK
$180M
| $47.6K | ﹤0.01% |
1,567
-86,233
| -98% | -$2.71M |
|
1679
Sinclair Inc
SBGI
$1.02B
| $47.1K | ﹤0.01% |
+2,917
| New | +$49.2K |
|
1680
Photronics
PLAB
$1.61B
| $47.1K | ﹤0.01% |
+1,998
| New | +$48.9K |
|
1681
Compass
COMP
$7.95B
| $47.1K | ﹤0.01% |
8,043
-2,127
| -21% | -$13.5K |
|
1682
Pliant Therapeutics
PLRX
$69.4M
| $47K | ﹤0.01% |
3,572
+1,363
| +62% | +$18.6K |
|
1683
Cullinan Oncology
CGEM
$1.32B
| $46.3K | ﹤0.01% |
3,802
+1,525
| +67% | +$21.9K |
|
1684
Camden National
CAC
$986M
| $46.2K | ﹤0.01% |
+1,082
| New | +$47.7K |
|
1685
Erasca
ERAS
$5.68B
| $46.2K | ﹤0.01% |
18,412
+747
| +4% | +$2.05K |
|
1686
Community Trust Bancorp
CTBI
$1.41B
| $46K | ﹤0.01% |
+868
| New | +$47.6K |
|
1687
Tapestry
TPR
$23.4B
| $45.9K | ﹤0.01% |
702
-3,824
| -84% | -$209K |
|
|
RNAM
1688
DELISTED
Avidity Biosciences
RNAM
| $45.9K | ﹤0.01% |
1,577
-25,557
| -94% | -$1.07M |
|
1689
Burke & Herbert Financial Services Corp
BHRB
$1.44B
| $45.6K | ﹤0.01% |
732
-39
| -5% | -$2.55K |
|
1690
IES Holdings
IESC
$12.4B
| $45.6K | ﹤0.01% |
454
-174
| -28% | -$20.9K |
|
1691
Concentrix
CNXC
$1.78B
| $45.6K | ﹤0.01% |
1,053
-1,438
| -58% | -$64K |
|
|
TDAY
1692
USA Today Co
TDAY
$966M
| $45.6K | ﹤0.01% |
9,004
-187
| -2% | -$993 |
|
1693
Hanmi Financial
HAFC
$954M
| $45.5K | ﹤0.01% |
1,928
-712
| -27% | -$16.7K |
|
1694
MasterBrand
MBC
$1.42B
| $45.5K | ﹤0.01% |
3,113
-278
| -8% | -$4.74K |
|
1695
Loews
L
$22.3B
| $45.5K | ﹤0.01% |
537
-588
| -52% | -$48.5K |
|
1696
DHT Holdings
DHT
$3.57B
| $45.5K | ﹤0.01% |
4,893
+265
| +6% | +$2.72K |
|
1697
Universal Logistics Holdings
ULH
$497M
| $45.3K | ﹤0.01% |
986
-192
| -16% | -$8.94K |
|
1698
UFP Technologies
UFPT
$2.13B
| $45.2K | ﹤0.01% |
185
+38
| +26% | +$11.1K |
|
1699
Intellia Therapeutics
NTLA
$1.59B
| $44.8K | ﹤0.01% |
3,845
-2,736,920
| -100% | -$42.7M |
|
1700
Ibotta
IBTA
$847M
| $44.6K | ﹤0.01% |
685
-5,315
| -89% | -$369K |
|
Similar funds
Federated Hermes's Q4 2024 Portfolio in Review
As of Q4 2024, Federated Hermes held 2,228 positions worth $45.7B, up 0.25% from $45.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Federated Hermes's Q4 2024 filing shows 172 new, 849 increased, 944 reduced and 160 closed positions. Its largest new stake was StandardAero Inc: 2,510,500 shares worth $62.2M. The largest sale was Entergy, an estimated $152M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- Federated Hermes's largest Q4 2024 buy was StandardAero Inc: 2,510,500 shares worth $62.2M.
- Federated Hermes added most to ExxonMobil in Q4 2024, an estimated $176M increase.
- Federated Hermes's biggest Q4 2024 reduction was Entergy, cutting an estimated $152M.
- Federated Hermes fully exited Huazhu Hotels Group in Q4 2024, selling an estimated $75.1M.
- Federated Hermes's ten largest holdings make up 14% of its $45.7B portfolio in Q4 2024.
- Federated Hermes opened 172 new positions and closed 160 in Q4 2024.
- Federated Hermes's portfolio value rose 0.25% quarter-over-quarter to $45.7B.
Based on Federated Hermes's 13F filing for Q4 2024, filed 13 Feb 2025.